Skip to main content
GutCited

Curcumin per Irritable Bowel Syndrome (IBS)

C

Small RCTs suggest improvement in IBS symptoms. Anti-inflammatory mechanism plausible but evidence insufficient for strong recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

In sintesi

Small RCTs suggest improvement in IBS symptoms. Anti-inflammatory mechanism plausible but evidence insufficient for strong recommendation.

Key Study Findings

Review
Plant-Derived Treatments for IBS: Clinical Outcomes, Mechanistic Insights, and Their Position in International Guidelines.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: patients with IBS (review of plant extracts including peppermint oil, Iberogast, curcumin)

Review
Curcumin in Inflammatory Complications: Therapeutic Applications and Clinical Evidence.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Review of curcumin in inflammatory complications

Systematic Review n=1123 Double-blind
Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic …
Dose: None vs: Placebo/control Outcome: Depression and anxiety in chronic diseases Effetto: SMD -0.65 [-1.16, -0.13] depression; SMD -0.22 [-0 0.01 (both)

Popolazione: Adults with chronic diseases and depression/anxiety (15 RCTs)

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None vs: Various Outcome: IBS symptom improvement Effetto: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

Popolazione: Adult IBS patients

Review
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Review of herbal remedies for IBS

Systematic Review
A systematic review of the efficacy and safety of turmeric in the treatment of digestive …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: IBS patients

Key Statistics

2

Studi

200

Partecipanti

Positive

C

Grado

Referenced Papers

The American journal … 2019 15 citazioni
Current gastroenterology reports 2017 16 citazioni
The Medical clinics … 2017 9 citazioni
Current gastroenterology reports 2016 30 citazioni
Molecular nutrition & … 2013 395 citazioni
Indian journal of … 2010 14 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
500-1,500 mg/day with piperine (black pepper extract) for absorption
ibssupport:
500-1,000 mg/day
ucmaintenance:
2,000 mg/day (1 g twice daily) as adjunct to mesalamine

Limite massimo: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Mixed --
None -- Mixed --
None -- Positive 1123
None -- Positive --
None -- Mixed --
None -- Neutral --
Peppermint oil, STW-5, psyllium, others -- Positive --
200 mg 8 weeks Positive --

Momento migliore per l'assunzione: With meals containing fat and black pepper for enhanced absorption

Safety & Side Effects

Effetti collaterali segnalati

  • GI discomfort (nausea, diarrhea, abdominal pain) at high doses
  • Yellow staining of skin/teeth with topical/oral contact
  • Increased gallbladder contractions (avoid with gallstones or bile duct obstruction)
  • Iron chelation (may reduce iron absorption at very high doses)

Interazioni note

  • Anticoagulants (curcumin has antiplatelet properties; may increase bleeding risk)
  • Chemotherapy agents (curcumin may alter drug metabolism via CYP enzyme inhibition)
  • Sulfasalazine (additive anti-inflammatory effect — may be beneficial in IBD)
  • Iron supplements (curcumin may chelate iron; space dosing)
  • Piperine/black pepper (enhances curcumin bioavailability by 2,000% — commonly co-administered)

Livello di assunzione massimo tollerabile: Well-tolerated up to 8 g/day in clinical trials (most studies use 1-2 g/day)

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Curcumin help with Irritable Bowel Syndrome (IBS)?
Based on 2 studies with 200 participants, there is limited but promising evidence that Curcumin may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day with piperine (black pepper extract) for absorption. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include GI discomfort (nausea, diarrhea, abdominal pain) at high doses, Yellow staining of skin/teeth with topical/oral contact, Increased gallbladder contractions (avoid with gallstones or bile duct obstruction), Iron chelation (may reduce iron absorption at very high doses). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.